Corrine Savill

Companies

• Cullinan OncologyActing Chief Business Officer Jan 7, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• COCullinan Oncology CGEM240,990 shares²$3.3M at $13.68Feb 19, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 19, 2025Granted 37,500 shares of Cullinan Oncology²
• Feb 22, 2024Granted 37,500 shares of Cullinan Oncology³
• Feb 1, 2024Sold 40,000 shares at $16.18 of Cullinan Oncology⁴
• Feb 1, 2024Exercised options 40,000 shares at $4.30 of Cullinan Oncology⁴
• Jan 29, 2024Sold 40,000 shares at $14.09 of Cullinan Oncology⁵
• Jan 29, 2024Exercised options 40,000 shares at $4.30 of Cullinan Oncology⁵
• Jan 23, 2024Sold 21,316 shares at $12.46 of Cullinan Oncology⁶
• Jan 23, 2024Exercised options 21,316 shares at $4.30 of Cullinan Oncology⁶
• Jan 22, 2024Sold 4,125 shares at $12.02 of Cullinan Oncology⁶
• Jan 22, 2024Sold 14,559 shares at $12.18 of Cullinan Oncology⁶
• Jan 22, 2024Exercised options 14,559 shares at $4.30 of Cullinan Oncology⁶
• Feb 17, 2023Granted 20,500 shares of Cullinan Oncology⁷
• Jul 19, 2022Sold 14,958 shares at $15.22 of Cullinan Oncology⁸
• Jul 18, 2022Sold 5,042 shares at $15.06 of Cullinan Oncology⁸
• Jul 11, 2022Sold 200 shares at $13.85 of Cullinan Oncology⁹
• Jul 11, 2022Sold 39,800 shares at $13.33 of Cullinan Oncology⁹
• Feb 11, 2022Granted 16,500 shares of Cullinan Oncology¹⁰